Dose Ranging Study of Indacaterol in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The study was designed to obtain data about the efficacy and safety of 3 doses of indacaterol
(150, 300, and 600 µg) in Japanese patients with chronic obstructive pulmonary disease (COPD)
so that optimal dose(s) could be chosen for testing in later studies.